International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8053805
Original Article
Prognostic Evaluation of Nutritional Status in Hospitalized Geriatric Covid- 19 Patients
 ,
 ,
 ,
 ,
 ,
 ,
 ,
Published
June 19, 2023
Abstract
Background: The elderly are more likely to develop symptomatic severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection. Malnutrition is a risk factor that can affect the clinical course of disease and physical and mental performance. Objective: To assess the nutritional status of geriatric patients using the modified nutritional risk in critically ill patients (mNUTRIC) and the geriatric nutritional risk index (GNRI), and evaluate the prognosis with the short-term outcome. Methods: A number of elderly individuals (> 65 years) hospitalised with COVID -19 were included in the study. Data on demographics, laboratory results, and concomitant diseases were collected. The geriatric nutritional risk index (GNRI) and modified nutritional risk index for critically ill patients (mNUTRIC) were used to assess nutritional status. For statistical analysis, categorical data were analysed with the Pearson chi-square test and continuous variables were analysed with the unpaired Student's t test. Results: A total of 86 (59.27%) were survivors and 58 (40.28%) were nonsurvivors. The mean value of APACHE II and SOFA was significantly increased in the nonsurvivors compared with the survivor group. Mean GNRI and mNUTRIC values were 87.93±8.49 and 2.41±0.82 in survivors and 81.40±6.32 and 4.78±1.39 in the survivor group. The mean GNRI and mNUTRIC were significantly different between the survivor and non-survivor groups Conclusion: GNRI was significantly lower and mNUTRIC was significantly higher in the non-survivor group compared with the survivor group. The change in GNRI was significantly negatively correlated with mortality and MNUTRIC was significantly positively correlated with mortality.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
2223 Views
401 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved